天坛生物(600161) - 2014 Q4 - 年度业绩预告

Financial Performance - The company expects a net profit attributable to shareholders for 2014 to decrease by approximately 50% compared to the previous year[3] - The net profit for the previous year was 372.0288 million yuan[4] - The earnings per share for the previous year was 0.72 yuan[4] Reasons for Profit Reduction - The main reason for the profit reduction is increased losses due to overall relocation and higher financial expenses[5] Forecast and Reporting - The forecast data is preliminary and subject to change based on the audited annual report[6]